{"entity":{"type":"insider","cik":"0001507502","url":"/insider/0001507502","json_url":"/insider/0001507502.json","name":"Kaldor Stephen W","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":2,"first":"2013-03-13","last":"2013-03-14","span_basis":"filed_date"},"name_variants":[{"name":"Kaldor Stephen W","source":"filing","n_filings":2,"first_seen":"2013-03-13","last_seen":"2013-03-14"}],"transactions":[{"id":9252831,"accession":"0001181431-13-017026","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-13-017026","line_url":"/filing/0001181431-13-017026#line-3","is_derivative":false,"issuer_cik":"0001484478","issuer_name":"Furiex Pharmaceuticals, Inc.","issuer_ticker":"FURX","issuer_name_source":null,"issuer_url":"/issuer/0001484478","owner_cik":"0001507502","owner_name":"Kaldor Stephen W","owner_display_name":"Kaldor Stephen W","owner_url":"/insider/0001507502","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1648.0,"shares_display":"1,648","price_per_share":39.96,"price_display":"39.96","price_state":"stated","total_value":65854.08,"total_display":"65,854.08","total_whole":"65,854","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-13","filed_date":"2013-03-14","scope":"insider"},{"id":9252833,"accession":"0001181431-13-017026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-017026","line_url":"/filing/0001181431-13-017026#line-2","is_derivative":false,"issuer_cik":"0001484478","issuer_name":"Furiex Pharmaceuticals, Inc.","issuer_ticker":"FURX","issuer_name_source":null,"issuer_url":"/issuer/0001484478","owner_cik":"0001507502","owner_name":"Kaldor Stephen W","owner_display_name":"Kaldor Stephen W","owner_url":"/insider/0001507502","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":973.0,"shares_display":"973","price_per_share":40.71,"price_display":"40.71","price_state":"stated","total_value":39610.83,"total_display":"39,610.83","total_whole":"39,611","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-12","filed_date":"2013-03-14","scope":"insider"},{"id":5505568,"accession":"0001181431-13-016742","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-13-016742","line_url":"/filing/0001181431-13-016742#line-3","is_derivative":false,"issuer_cik":"0001484478","issuer_name":"Furiex Pharmaceuticals, Inc.","issuer_ticker":"FURX","issuer_name_source":null,"issuer_url":"/issuer/0001484478","owner_cik":"0001507502","owner_name":"Kaldor Stephen W","owner_display_name":"Kaldor Stephen W","owner_url":"/insider/0001507502","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":973.0,"shares_display":"973","price_per_share":40.71,"price_display":"40.71","price_state":"stated","total_value":39610.83,"total_display":"39,610.83","total_whole":"39,611","shares_owned_after":1648.0,"shares_owned_after_display":"1,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-12","filed_date":"2013-03-13","scope":"insider"},{"id":9252832,"accession":"0001181431-13-017026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-017026","line_url":"/filing/0001181431-13-017026#line-1","is_derivative":false,"issuer_cik":"0001484478","issuer_name":"Furiex Pharmaceuticals, Inc.","issuer_ticker":"FURX","issuer_name_source":null,"issuer_url":"/issuer/0001484478","owner_cik":"0001507502","owner_name":"Kaldor Stephen W","owner_display_name":"Kaldor Stephen W","owner_url":"/insider/0001507502","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5379.0,"shares_display":"5,379","price_per_share":41.74,"price_display":"41.74","price_state":"stated","total_value":224519.46,"total_display":"224,519.46","total_whole":"224,519","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-11","filed_date":"2013-03-14","scope":"insider"},{"id":5505564,"accession":"0001181431-13-016742","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-016742","line_url":"/filing/0001181431-13-016742#line-2","is_derivative":false,"issuer_cik":"0001484478","issuer_name":"Furiex Pharmaceuticals, Inc.","issuer_ticker":"FURX","issuer_name_source":null,"issuer_url":"/issuer/0001484478","owner_cik":"0001507502","owner_name":"Kaldor Stephen W","owner_display_name":"Kaldor Stephen W","owner_url":"/insider/0001507502","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5379.0,"shares_display":"5,379","price_per_share":41.74,"price_display":"41.74","price_state":"stated","total_value":224519.46,"total_display":"224,519.46","total_whole":"224,519","shares_owned_after":2621.0,"shares_owned_after_display":"2,621","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-11","filed_date":"2013-03-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001484478","name":"Furiex Pharmaceuticals, Inc.","url":"/issuer/0001484478","role":"Director","n_filings":2,"first_seen":"2013-03-13","last_seen":"2013-03-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001507502","retrieved_at":"2026-08-27T15:09:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}